Locust Walk is pleased to announce that our client Strongbridge Biopharma recently completed its NASDAQ IPO, our first completed IPO advisory assignment. The company engaged the Locust Walk team to assist with a variety of buy side and financing activities that led to...
Here at Locust Walk, we have the pleasure to work alongside many who are transforming the healthcare industry, including those who focus in the men’s health sector. We are proud to join the Movember Foundation in their annual “Moustaches in Movember”...
This healthcare conversation included a panel of experts: Alex Denner, PhD, a Founding Partner and Chief Investment Officer of Sarissa Capital Management LP Bill Jenks, head of the US office of KPMG Makinson Cowell, a global investor relations consultancy Doron Levit,...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a collaboration with Mitsubishi Tanabe Pharma Corporation (TSE: 4508) (MTPC) providing MTPC with exclusive development and commercial rights to fasinumab (REGN475), Regeneron’s NGF antibody in late-stage...
Armetheon and Lee’s Pharma Enter into Agreement to Develop and Commercialize Tecarfarin in Greater China and Thailand MILPITAS, Calif. and HONG KONG, Sept. 22, 2015 /PRNewswire/ — Armetheon, Inc., a specialty pharmaceutical company developing novel small...
